Inventor · disambiguated record
David Gerring
Also filed as: GERRING DAVID
7 granted patents·28 pending applications·7 citations·filing 2017–2025
75Inventor score
Top patents by PatentIndex Score
35 records- 0186US11278624B2FormulationsARECOR LTD·Filed 2017·Granted Mar 22, 2022·5 cites·24 claims
- 0278US11291725B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2017·Granted Apr 5, 2022·1 cites·18 claims
- 0377US11534402B2Liquid pharmaceutical compositionARECOR LTD·Filed 2018·Granted Dec 27, 2022·1 cites·25 claims
- 0473US2025099593A1FormulationsARECOR LTD·Filed 2024·Application pending·0 cites
- 0569US2025177501A1Aqueous solution compositions for increasing stability of engineered dimeric proteinsARECOR LTD·Filed 2024·Application pending·0 cites
- 0666US2023233463A1Liquid pharmaceutical compositionARECOR LTD·Filed 2022·Application pending·0 cites
- 0766US2023330014A1Liquid pharmaceutical compositionARECOR LTD·Filed 2022·Application pending·0 cites
- 0865US2022184213A1Novel formulationsARECOR LTD·Filed 2022·Application pending·0 cites
- 0963US2025302735A1Injection pen system for the delivery of an insulin compoundARECOR LTD·Filed 2025·Application pending·0 cites
- 1062US12357562B2Injection pen system for the delivery of an insulin compoundARECOR LTD·Filed 2019·Granted Jul 15, 2025·0 cites·54 claims
- 1162US12239685B2CompositionARECOR LTD·Filed 2019·Granted Mar 4, 2025·0 cites·15 claims
- 1261US11608357B2Stabilized antibody protein solutionsARECOR LTD·Filed 2019·Granted Mar 21, 2023·0 cites·47 claims
- 1361US2023414753A1Stabilized antibody protein solutionsARECOR LTD·Filed 2023·Application pending·0 cites
- 1461US2022175924A1Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2022·Application pending·0 cites
- 1560US11534403B2Liquid pharmaceutical compositionARECOR LTD·Filed 2018·Granted Dec 27, 2022·0 cites·23 claims
- 1659US2022265788A1Aqueous solution compositions for increasing stability of engineered dimeric proteinsARECOR LTD·Filed 2022·Application pending·0 cites
- 1759US2023277453A1Stabilized antibody protein solutionsARECOR LTD·Filed 2023·Application pending·0 cites
- 1859US2025241981A1Novel compositionARECOR LTD·Filed 2025·Application pending·0 cites
- 1957US2022288165A1Novel composition comprising antibodiesARECOR LTD·Filed 2020·Application pending·0 cites
- 2056US2024166718A1Aqueous composition of an engineered protein construct comprising an fc domainARECOR LTD·Filed 2022·Application pending·0 cites
- 2152US2025268987A1FormulationsARECOR LTD·Filed 2025·Application pending·0 cites
- 2252US2020093894A1Novel formulationsARECOR LTD·Filed 2018·Application pending·0 cites
- 2351US2021085751A1Novel compositionArecor Limted·Filed 2018·Application pending·0 cites
- 2448US2022080023A1Novel compositionARECOR LTD·Filed 2019·Application pending·0 cites
- 2548US2023181675A1Novel formuationsARECOR LTD·Filed 2021·Application pending·0 cites
- 2645US2020069799A1Stabilized antibody protein solutionsARECOR LTD·Filed 2019·Application pending·0 cites
- 2745US2021113763A1Medical infusion pump system for the delivery of an insulin compoundARECOR LTD·Filed 2019·Application pending·0 cites
- 2845US2021093775A1Medical infusion pump system for the delivery of an insulin compoundARECOR LTD·Filed 2019·Application pending·0 cites
- 2944US2020023062A1Stabilized antibody protein solutionsARECOR LTD·Filed 2018·Application pending·0 cites
- 3043US2022125718A1STABILIZED Fc FUSION PROTEIN SOLUTIONSARECOR LTD·Filed 2020·Application pending·0 cites
- 3141US2020093895A1Stable insulin formulationsARECOR LTD·Filed 2018·Application pending·0 cites
- 3240US2019183980A1Insulin glargineARECOR LTD·Filed 2017·Application pending·0 cites
- 3340US2019175737A1Insulin glargine and triethylenetetramine (teta)ARECOR LTD·Filed 2017·Application pending·0 cites
- 3440US2020023061A1Stabilized antibody solutionsARECOR LTD·Filed 2018·Application pending·0 cites
- 3538US2020222508A1Glucagon-like peptide 1 (glp-1) receptor agonist compositionsARECOR LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Gerring files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →